Literature DB >> 1309644

Viremic dissemination of mouse hepatitis virus-JHM following intranasal inoculation of mice.

S W Barthold1, A L Smith.   

Abstract

Using a sensitive infant mouse bioassay to detect infectious virus, the pattern of mouse hepatitis virus (MHV) JHM dissemination in blood and other tissues was examined during the first 5 days following intranasal inoculation. MHV replicated in nasal turbinates of both susceptible BALB and resistant SJL mice from days 1 through 5, but BALB mice had higher titers on days 1 and 2. Viremia was detectable on days 1 through 5 in BALB mice, but only on days 3 and 5 in SJL mice. Transient virus replication occurred in the lungs of both mouse genotypes at 1 and 2 days, then ceased. This correlated with more consistently demonstrable virus in blood collected from the left atrium of the heart, compared to jugular vein, portal vein and right atrial blood. Virus was associated equally with the plasma and cellular fractions of blood on day 3, but was primarily in the buffy coat of the cellular fraction on day 5. Interferon-alpha/beta was detected in serum and spleen, but not liver or brain of BALB mice or in any tissue of SJL mice. BALB serum and spleen interferon was first detected at 36 h, peaked between 48 and 72 h, and was undetectable by 108 h. The distribution of virus in nose, cervical, axillary and mesenteric lymph nodes, spleen, Peyer's patch, thymus, bone marrow and liver was examined at 1, 2, and 3 days. The resulting pattern suggested lymphatic spread of virus to cervical lymph node and mesenteric lymph node as pathways of dissemination in addition to viremia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1309644      PMCID: PMC7086624          DOI: 10.1007/bf01321116

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  24 in total

1.  Pulmonary vascular lesions in nude mice persistently infected with mouse hepatitis virus.

Authors:  T Furuta; Y Goto; T Tamura; C Kai; K Ueda
Journal:  Jpn J Exp Med       Date:  1979-12

2.  Effects of cortisone on interferon response of germfree mice to mouse hepatitis virus.

Authors:  G C Lavelle; T J Starr
Journal:  J Reticuloendothel Soc       Date:  1968-10

3.  The fate of murine hepatitis virus (MHV-3) after intravenous injection into susceptible mice.

Authors:  M Piazza; G Pane; F De Ritis
Journal:  Arch Gesamte Virusforsch       Date:  1967

4.  Convenient assay for interferons.

Authors:  S Rubinstein; P C Familletti; S Pestka
Journal:  J Virol       Date:  1981-02       Impact factor: 5.103

Review 5.  The biology and pathogenesis of coronaviruses.

Authors:  H Wege; S Siddell; V ter Meulen
Journal:  Curr Top Microbiol Immunol       Date:  1982       Impact factor: 4.291

6.  Activation of natural killer cells and induction of interferon after injection of mouse hepatitis virus type 3 in mice.

Authors:  L Schindler; H Engler; H Kirchner
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

7.  MHV-A59 pathogenesis in mice.

Authors:  E Lavi; D H Gilden; M K Highkin; S R Weiss
Journal:  Adv Exp Med Biol       Date:  1984       Impact factor: 2.622

8.  Purification of the 110-kilodalton glycoprotein receptor for mouse hepatitis virus (MHV)-A59 from mouse liver and identification of a nonfunctional, homologous protein in MHV-resistant SJL/J mice.

Authors:  R K Williams; G S Jiang; S W Snyder; M F Frana; K V Holmes
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

9.  Difference in response to mouse hepatitis virus among susceptible mouse strains.

Authors:  F Taguchi; N Hirano; Y Kiuchi; K Fujiwara
Journal:  Jpn J Microbiol       Date:  1976-08

10.  Mouse hepatitis virus strain--related patterns of tissue tropism in suckling mice.

Authors:  S W Barthold; A L Smith
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

View more
  14 in total

Review 1.  Natural pathogens of laboratory mice, rats, and rabbits and their effects on research.

Authors:  D G Baker
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

2.  Neuroinvasion by human respiratory coronaviruses.

Authors:  N Arbour; R Day; J Newcombe; P J Talbot
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

3.  Acute and persistent infection of human neural cell lines by human coronavirus OC43.

Authors:  N Arbour; G Côté; C Lachance; M Tardieu; N R Cashman; P J Talbot
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

4.  Persistent infection of human oligodendrocytic and neuroglial cell lines by human coronavirus 229E.

Authors:  N Arbour; S Ekandé; G Côté; C Lachance; F Chagnon; M Tardieu; N R Cashman; P J Talbot
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

5.  Cytokine induction during T-cell-mediated clearance of mouse hepatitis virus from neurons in vivo.

Authors:  B D Pearce; M V Hobbs; T S McGraw; M J Buchmeier
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

6.  Prevalence of viral antibodies and helminths in field populations of house mice (Mus domesticus) in southeastern Australia.

Authors:  G R Singleton; A L Smith; G R Shellam; N Fitzgerald; W J Müller
Journal:  Epidemiol Infect       Date:  1993-04       Impact factor: 2.451

7.  Priming of CD8+ T cells during central nervous system infection with a murine coronavirus is strain dependent.

Authors:  Katherine C MacNamara; Susan J Bender; Ming Ming Chua; Richard Watson; Susan R Weiss
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

8.  The Role of Host Genetic Factors in Coronavirus Susceptibility: Review of Animal and Systematic Review of Human Literature.

Authors:  Marissa LoPresti; David B Beck; Priya Duggal; Derek A T Cummings; Benjamin D Solomon
Journal:  medRxiv       Date:  2020-06-03

Review 9.  Infectivity of human coronavirus in the brain.

Authors:  Qi Cheng; Yue Yang; Jianqun Gao
Journal:  EBioMedicine       Date:  2020-05-28       Impact factor: 8.143

Review 10.  Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2.

Authors:  Robert W Körner; Mohamed Majjouti; Miguel A Alejandre Alcazar; Esther Mahabir
Journal:  Viruses       Date:  2020-08-12       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.